⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1893054 | 0.97 | — | — | |
| Iodide SCHEMBL1892715 | 0.97 | — | — | |
| Phosphoric Acid SCHEMBL11762462 | 0.89 | NOS3 (0.42) | — | |
| Sulfuric Acid SCHEMBL919865 | 0.89 | NOS3 (0.42) | — | |
| Ether SCHEMBL9102054 | 0.87 | NOS3 (0.37) | — | |
| SCHEMBL4110084 | 0.84 | — | — | |
| SCHEMBL4108199 | 0.82 | NOS3 (0.48) | — | |
| SCHEMBL4099231 | 0.80 | NOS3 (0.47) | — | |
| SCHEMBL4103953 | 0.80 | NOS3 (0.47) | — | |
| SCHEMBL9059422 | 0.78 | NOS3 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4522145-A1 | COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF POST VIRAL FATIGUE SYNDROME | AlzChem Trostberg GmbH (DE) | 2025-03-19 | — | — | EP | claimed |
| EP-4522144-A1 | COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF BREATHING DIFFICULTIES | Alzchem Trostberg GmbH (DE) | 2025-03-19 | — | — | EP | claimed |
| EP-4311549-A1 | COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF POST VIRAL FATIGUE SYNDROME | AlzChem Trostberg GmbH (DE) | 2024-01-31 | — | — | EP | claimed |
| WO-2023217993-A1 | COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF BREATHING DIFFICULTIES | ALZCHEM TROSTBERG GMBH (DE) | 2023-11-16 | — | — | WO | claimed |
| WO-2023217994-A1 | COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF POST VIRAL FATIGUE SYNDROME | ALZCHEM TROSTBERG GMBH (DE) | 2023-11-16 | — | — | WO | claimed |
| EP-4275680-A1 | COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF BREATHING DIFFICULTIES | AlzChem Trostberg GmbH (DE) | 2023-11-15 | — | — | EP | claimed |
| US-20230165868-A1 | PARAXANTHINE-BASED COMPOSITIONS FOR ENHANCING MUSCLE FUNCTION, NITRIC OXIDE SIGNALING, AND/OR MUSCLE GLYCOGEN LEVELS | PX ING, LLC | 2023-06-01 | — | — | US | claimed |
| WO-2023097091-A1 | PARAXANTHINE-BASED COMPOSITIONS FOR ENHANCING MUSCLE FUNCTION, NITRIC OXIDE SIGNALING, AND/OR MUSCLE GLYCOGEN LEVELS | Ingenious Ingredients, LP (US) | 2023-06-01 | — | — | WO | claimed |
| CN-107382790-A | The phosphatic synthetic method of creatinol | 泰山医学院 | 2017-11-24 | — | — | CN | claimed |
| CN-106188131-A | A kind of preparation method of meat alcohol phosphate ester | 启东瑞华药业有限公司 | 2016-12-07 | — | — | CN | claimed |
| EP-1532963-A1 | Composition for straightening the hair comprising at least one imine not being an hydroxide | L'OREAL (FR) | 2005-05-25 | — | — | EP | claimed |
| EP-1532960-A1 | Hair styling composition containing a non-hydroxide imine | L'OREAL (FR) | 2005-05-25 | — | — | EP | claimed |
| WO-2000043022-A1 | UTILIZATION OF FORMULATIONS BASED ON WATER-SOLUBLE FRACTIONS OF PHLEBODIUM DECUMANUM(EXPLY-37) AND POLYPODIUM LEUCOTOMOS AS NUTRITIONAL SUPPLEMENT IN THE PREVENTION AND REVERSION OF EXCESSIVE PHYSICAL EFFORT SYNDROME | HELSINT, S.A.L. (ES) | 2000-07-27 | — | — | WO | claimed |
| EP-0426100-B1 | Stabilized enzyme compositions | ABBOTT LAB (US) | 1994-12-14 | — | — | EP | claimed |
| EP-0371874-A1 | Topical slimming agents containing caffein carboxylic acids neutralised by organic bases, and preparations for the treatment of cellulitis | PIERRE FABRE COSMETIQUE (FR) | 1990-06-06 | — | — | EP | claimed |
| EP-0150206-A4 | PYRIDINYL-2-PYRIMIDINAMINES USEFUL AS CARDIOTONICS AND PREPARATION THEREOF. | STERLING DRUG INC (US) | 1986-03-18 | — | — | EP | claimed |
| EP-0150206-A1 | PYRIDINYL-2-PYRIMIDINAMINES USEFUL AS CARDIOTONICS AND PREPARATION THEREOF | STERLING DRUG INC. (US) | 1985-08-07 | — | — | EP | claimed |
| WO-1985000604-A1 | PYRIDINYL-2-PYRIMIDINAMINES USEFUL AS CARDIOTONICS AND PREPARATION THEREOF | STERLING DRUG INC. (US) | 1985-02-14 | — | — | WO | claimed |
| EP-0017525-A1 | Derivatives of tetrahydroalstonine, their preparation and their application as medicaments | PIERRE FABRE S.A. (FR) | 1980-10-15 | — | — | EP | claimed |
| US-4012467-A | Process for preparing an ester of the N-methyl-N-hydroxyethylguanidine | ALLIEVI ELIO | 1977-03-15 | — | — | US | claimed |